Telomir Pharmaceuticals, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
Telomir Pharmaceuticals, Inc. Common Stock Earnings Date And Information
Telomir Pharmaceuticals, Inc. Common Stock last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Telomir Pharmaceuticals, Inc. Common Stock has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -5.45. Telomir Pharmaceuticals, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Telomir Pharmaceuticals, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.05 | -$0.20 | -0.15 | $0 | |
| 08/13/2024 | Q2 2024 | -$0.05 | $0 | |||
| 05/13/2024 | Q1 2024 | -$0.23 | $0 | |||
| 03/29/2024 | Q4 2023 | -$0.32 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.06 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.05 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.02 | $0 | |||
| 12/29/2022 | Q4 2022 | -$0.02 | $0 | |||
| 09/28/2022 | Q3 2022 | -$0.01 | $0 | |||
| 06/28/2022 | Q2 2022 | -$0.00 | $0 | |||
| 03/29/2022 | Q1 2022 | -$0.00 | $0 |
Telomir Pharmaceuticals, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Telomir Pharmaceuticals, Inc. Common Stock's earnings date?
Telomir Pharmaceuticals, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Telomir Pharmaceuticals, Inc. Common Stock's earnings conference call?
The conference call for Telomir Pharmaceuticals, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Telomir Pharmaceuticals, Inc. Common Stock's conference call transcript?
The conference call transcript for Telomir Pharmaceuticals, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Telomir Pharmaceuticals, Inc. Common Stock generate each year?
Telomir Pharmaceuticals, Inc. Common Stock (:TELO) has a recorded net income of $0. Telomir Pharmaceuticals, Inc. Common Stock has generated $-0.44 earnings per share over the last four quarters.
-
What is Telomir Pharmaceuticals, Inc. Common Stock's price-to-earnings ratio?
Telomir Pharmaceuticals, Inc. Common Stock (:TELO) has a price-to-earnings ratio of -5.45 and price/earnings-to-growth ratio is 0.26.
